Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers.
about
Targeted therapies in breast cancer: New challenges to fight against resistance.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.Effects of Lysine deficiency and Lys-Lys dipeptide on cellular apoptosis and amino acids metabolism.Selumetinib-based therapy in uveal melanoma patient-derived xenografts.Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells.
P2860
Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting mTOR pathway inhibit ...... riple-negative breast cancers.
@en
Targeting mTOR pathway inhibit ...... riple-negative breast cancers.
@nl
type
label
Targeting mTOR pathway inhibit ...... riple-negative breast cancers.
@en
Targeting mTOR pathway inhibit ...... riple-negative breast cancers.
@nl
prefLabel
Targeting mTOR pathway inhibit ...... riple-negative breast cancers.
@en
Targeting mTOR pathway inhibit ...... riple-negative breast cancers.
@nl
P2093
P2860
P50
P356
P1433
P1476
Targeting mTOR pathway inhibit ...... triple-negative breast cancers
@en
P2093
Céline Callens
Dalila Labiod
Fabien Reyal
Florence Coussy
Franck Assayag
Jean-Luc Servely
Ludmilla de Plater
Rana Hatem
Sabina Cosulich
Sophie Chateau-Joubert
P2860
P304
48206-48219
P356
10.18632/ONCOTARGET.10195
P407
P577
2016-07-01T00:00:00Z